Litcius/Paper detail

MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation

Katja Seipel, Christian Messerli, Gertrud Wiedemann, Ulrike Bacher, Thomas Pabst

2020Leukemia Research26 citationsDOI

Topics & Concepts

Induction chemotherapyMedicineMyeloid leukemiaOncologyChemotherapyHematopoietic stem cell transplantationMyeloidInternal medicineCancer researchCD34TransplantationImmunologyStem cellBiologyGeneticsAcute Myeloid Leukemia ResearchMultiple Myeloma Research and TreatmentsMeningioma and schwannoma management
MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation | Litcius